Posts Feed
Comments Feed

European Medicines Agency Recommends Suspension Of Marketing Authorisations For Carisoprodol-containing Medicinal Products

The European Medicines Agency (EMEA) has recommended the suspension of marketing authorisations for all medicinal products containing carisoprodol. Carisoprodol products are available in 12 Member States under prescription, mainly for the treatment of acute lower back pain. [click link for full article]

More: continued here

No Comments »

Trackback URI | Comments RSS

Leave a Reply

You must be logged in to post a comment.

1